Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance
News Release
Prescriptions for Opioid Disorder Meds on Rise in Comp
Workers' Comp
News Release
Enlyte Names Steve Laudermilch EVP of Mitchell Casualty Solutions
P&C executive will head company’s auto casualty and workers’ comp technology division.
Workers' Comp
News Release
Enlyte Names Steve Laudermilch EVP of Mitchell Casualty Solutions Group
P&C executive will head company’s auto casualty and workers’ comp technology division. SAN DIEGO—Enlyte, th
Enlyte
News Release
Enlyte Names Steve Laudermilch EVP of Mitchell Casualty Solutions Group
P&C executive will head company’s auto casualty and workers’ comp technology division. SAN DIEGO—Enlyte, th
Workers' Comp
News Release
Kentucky Administrative Rule Updates
Two rules have recently been introduced in Kentucky that may impact your Utilization Review program: KAR 803 25:195E and KAR 803 35:195 Proposed.&n
mitchell
News Release
Beneva Selects Mitchell to Streamline Claims Management
Canadian insurer will leverage the company’s advanced technology to help simplify automotive claims processing and expedite settlement